The Physician-CEO Transforming Merck KGaA into a Global Powerhouse
In the dynamic world of global business leadership, few figures exemplify the fusion of scientific expertise and strategic acumen as profoundly as Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. Her journey from clinical pharmacologist to the helm of a 355-year-old science and technology conglomerate is a testament to visionary leadership and unwavering commitment to innovation, sustainability, and inclusivity.
From Clinical Practice to Corporate Leadership
Born in 1960 in Almansa, Spain, Garijo began her professional journey in medicine. After earning her Doctor of Medicine degree from the University of Alcalá, she specialized in clinical pharmacology and commenced her career at Hospital Universitario La Paz in Madrid. Her transition into the pharmaceutical industry saw her holding pivotal roles at Abbott Laboratories, Rhône-Poulenc Rorer, and Sanofi-Aventis, where she led the integration of Genzyme post-acquisition.
In 2011, Garijo joined Merck KGaA as Chief Operating Officer of its Biopharma division. Her strategic vision and leadership led to her appointment as President and CEO of the Healthcare business in 2015, and subsequently, in May 2021, she ascended to the role of CEO, becoming the first woman to lead the company in its extensive history.
Strategic Vision and Transformational Leadership
Under Garijo’s stewardship, Merck KGaA has undergone significant transformation, focusing on four strategic priorities:
- Cultivating a high-impact culture and leadership.
- Harnessing innovation powered by AI, data, and digital technologies.
- Driving efficient growth and sustainable performance.
- Creating long-term value through sustainability initiatives.
Her leadership has been instrumental in repositioning Merck’s Healthcare portfolio, reorganizing R&D, and realigning the commercial model, propelling the company to the forefront of oncology and immunology sectors.
Championing Diversity and Sustainability
Garijo’s tenure is marked by a steadfast commitment to diversity and environmental stewardship. She has been pivotal in increasing the representation of women in leadership roles at Merck, with women holding 39% of such positions as of 2024, aiming for gender parity by 2030.
On the sustainability front, Merck has achieved a 26% reduction in direct and indirect greenhouse gas emissions compared to the previous year, nearly halving total emissions since 2020, with ambitions to meet 2030 targets ahead of schedule.
Global Recognition and Influence
Garijo’s exemplary leadership has garnered international acclaim. She has been featured in Fortune’s “Most Powerful Women” list, ranking 30th in 2023, and Forbes’ “World’s 100 Most Powerful Women,” ranking 68th the same year.
Her influence extends beyond Merck, serving on various boards and councils, including Banco Bilbao Vizcaya Argentaria S.A., the EU-Japan Business Round Table, and the European Round Table for Industry, reflecting her commitment to fostering global collaboration and innovation.
A Legacy of Purpose-Driven Leadership
Belén Garijo’s journey from a medical practitioner to a global business leader encapsulates a narrative of resilience, innovation, and purpose. Her leadership at Merck KGaA not only exemplifies strategic excellence but also underscores a profound commitment to societal impact, setting a benchmark for future leaders in the intersection of science, technology, and business.
